Wu L - Search Results

1

DANCR Acts as a Diagnostic Biomarker and Promotes Tumor Growth and Metastasis in Hepatocellular Carcinoma.

Ma X, Wang X, Yang C, Wang Z, Han B, Wu L, Zhuang L. Ma X, et al. Among authors: wu l. Anticancer Res. 2016 Dec;36(12):6389-6398. doi: 10.21873/anticanres.11236. Anticancer Res. 2016. PMID: 27919960

2

Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.

Wu LQ, Lu Y, Wang XF, Lv ZH, Zhang B, Yang JY. Wu LQ, et al. Life Sci. 2006 Jul 17;79(8):744-8. doi: 10.1016/j.lfs.2006.02.024. Epub 2006 Feb 28. Life Sci. 2006. PMID: 16546222

3

[Prognostic value of E-cadherin, CD34 in the patients with hepatocellular carcinoma].

Wu LQ, Lu Y, Lu HJ, Zhang B, Yang JY, Ma X. Wu LQ, et al. Zhonghua Wai Ke Za Zhi. 2006 Jun 1;44(11):774-7. Zhonghua Wai Ke Za Zhi. 2006. PMID: 16836930 Chinese.

4

Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.

Lu Y, Wu LQ, Lü ZH, Wang XJ, Yang JY. Lu Y, et al. Chin Med J (Engl). 2007 Jun 20;120(12):1042-6. Chin Med J (Engl). 2007. PMID: 17637219

5

Caspase-3 gene transfected with LIGHT gene: can it be used for therapy of human hepatocellular carcinoma?

Lu Y, Wu LQ, Wang SG, Lv ZH, Han B. Lu Y, et al. Clin Chem Lab Med. 2008;46(4):470-4. doi: 10.1515/CCLM.2008.094. Clin Chem Lab Med. 2008. PMID: 18298346

6

Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.

Lu Y, Wu LQ, Li CS, Wang SG, Han B. Lu Y, et al. Hepatobiliary Pancreat Dis Int. 2008 Apr;7(2):174-8. Hepatobiliary Pancreat Dis Int. 2008. PMID: 18397854

7

Synergistic effect of IFN-γ gene on LIGHT-induced apoptosis in HepG2 cells via down regulation of Bcl-2.

Han B, Wu LQ, Ma X, Wang ZH, Li JP, Bi CY, Yong S. Han B, et al. Artif Cells Blood Substit Immobil Biotechnol. 2011 Aug;39(4):228-38. doi: 10.3109/10731199.2010.538403. Epub 2010 Nov 30. Artif Cells Blood Substit Immobil Biotechnol. 2011. PMID: 21117871

8

[Evaluation on short term after hepatectomy for the patients with primary hepatocellular carcinoma].

Wu LQ, Qiu FB, Zhang S, Zhang B, Guo WD, Cao JY, Wang ZS, Hu WY, Han B, Yang JY, Cui ZJ. Wu LQ, et al. Zhonghua Wai Ke Za Zhi. 2011 Sep 1;49(9):784-8. Zhonghua Wai Ke Za Zhi. 2011. PMID: 22177430 Chinese.

9

[CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].

Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY, Hu WY, Han B. Wang ZS, et al. Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):753-8. doi: 10.3760/cma.j.issn.0253-3766.2012.10.008. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23291069 Chinese.

10

Recombinant adenovirus vector-mediated human MDA-7 gene transfection suppresses hepatocellular carcinoma growth in a mouse xenograft model.

Pan X, Wu L, Cao J, Guo W, Wang Z, Han B, Hu W. Pan X, et al. Among authors: wu l. J Biomed Res. 2012 Jan;26(1):53-8. doi: 10.1016/S1674-8301(12)60007-4. J Biomed Res. 2012. PMID: 23554730 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,124 results

Search Page

Filters